Avigan

DRUG3 trials

Sponsors

Genuine Research Center, Egypt, Dr. Reddy's Laboratories Limited, Hayandra Peduli Foundation

Conditions

ARDS, HumanCovid19HealthySars-CoV-2 InfectionSevere covid19

Phase 1

Bioequivalence Study of Favipiravir From Flupirava 200 mg Tablet (European Egyptian Pharmaceutical Industries , Egypt) Versus Avigan 200 mg Tablets (Man. by Toyama Chemical Co., Ltd Japan)

CompletedNCT04478448

Genuine Research Center, EgyptHealthy

Start: 2020-08-13End: 2020-08-26Updated: 2020-09-02

Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy

Hayandra Peduli FoundationARDS, Human, Covid19, Sars-CoV-2 Infection +1

Start: 2020-12-29End: 2021-12-27Target: 30Updated: 2021-01-20

Phase 3

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

TerminatedNCT04529499

Dr. Reddy's Laboratories LimitedCovid19

Start: 2020-08-22End: 2021-01-27Updated: 2022-03-21